Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Neuland Laboratories Limited (NSE: NEULANDLAB), ISIN INE794A01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
NEULANDLAB last traded at ₹20292.70 (+3.01%), with a 52-week range of ₹11500.00 to ₹24225.00 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 32.26%, FIIs 21.93%, DIIs 16.25%, mutual funds 12.45%.
EquiSense Score (ECS): 42/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.